BackPrecidian ETFs Trust - Novo Nordisk A/S (B Shares) ADRhedged Overview

Precidian ETFs Trust - Novo Nordisk A/S (B Shares) ADRhedged Intangible Assets

Latest intangible assets for NVOH: $320M.

Get informed when a big investor buys or sells

+ Follow
Intangible Assets
$320.48M
↓ 1.98% YoYΔ $-6.48M vs prior year quarter

Peer trimmed avg / median

Loading

Precidian ETFs Trust - Novo Nordisk A/S (B Shares) ADRhedged Intangible Assets History

Loading

Precidian ETFs Trust - Novo Nordisk A/S (B Shares) ADRhedged vs. peers: Intangible Assets Comparison

Loading

Precidian ETFs Trust - Novo Nordisk A/S (B Shares) ADRhedged Intangible Assets Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Precidian ETFs Trust - Novo Nordisk A/S (B Shares) ADRhedged (NVOH) FAQ

The latest intangible assets for NVOH is $320M as of September 2016. That compares with $330M in the prior-year period — down 2.0% year over year. Investors often review this figure alongside Precidian ETFs Trust - Novo Nordisk A/S (B Shares) ADRhedged's historical trend and sector peers before judging valuation or financial health.

Over the past year, NVOH's intangible assets moved from $330M to $320M — a 2.0% year-over-year decrease. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in Precidian ETFs Trust - Novo Nordisk A/S (B Shares) ADRhedged's operating scale or balance-sheet position.

A intangible assets figure of $320M for NVOH is a snapshot of scale on that line item. On its own it does not say whether the business is healthy — you also want growth rate, margins, and how the number compares with similar companies. Explore the charts below for those layers of context.

After noting NVOH's intangible assets ($320M), review year-over-year change from $330M, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.